The committee’s vote Tuesday followed a decision by a federal vaccine advisory committee earlier this month to no longer recommend hepatitis B vaccines for all newborns.

The COVID-19 vaccines developed for the 2024-2025 respiratory disease season were around 75% effective at preventing ...

The American Academy of Pediatrics updated its COVID-19 vaccination recommendations for preventing severe disease in children.

Built into the 2026 guidance is a $1.5 billion decline in sales of its COVID products—from an estimated $6.5 billion this ...

Tailoring breast cancer screening to a woman's individual cancer risk might work better than annual mammograms, researchers ...

A Centers for Disease Control and Prevention committee voted to eliminate a recommendation that all newborn babies receive a vaccine against hepatitis B, ending a policy that has been in place since ...

These developments have prompted states to preserve scientifically backed services where they can: state-regulated private insurance plans, Medicaid, and public health programs. State policymakers ...

COVID-19, RSV, and influenza immunizations show continued safety and substantial effectiveness against hospitalization across various populations.

Federal policy changes under the Trump administration could reverse New York City’s historic rise in life expectancy, the ...

Controversy erupted when a CDC panel changed recommendations for hepatitis B vaccines. These Michigan health systems say they ...

It's too soon to know if the trend will last. But health providers fear the national discourse around vaccines could yield more sickness and death this winter.

Under the direction of Robert F. Kennedy Jr., federal health officials have changed guidance on hepatitis B vaccines, ...